368 related articles for article (PubMed ID: 7526723)
1. On the discriminatory value of anti-HPCA-1 (CD-34) in the differential diagnosis of benign and malignant cutaneous vascular proliferations.
Suster S; Wong TY
Am J Dermatopathol; 1994 Aug; 16(4):355-63. PubMed ID: 7526723
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous vascular proliferation. Part II. Hyperplasias and benign neoplasms.
Requena L; Sangueza OP
J Am Acad Dermatol; 1997 Dec; 37(6):887-919; quiz 920-2. PubMed ID: 9418757
[TBL] [Abstract][Full Text] [Related]
3. Cytokeratin expression in epithelioid vascular neoplasms.
Gray MH; Rosenberg AE; Dickersin GR; Bhan AK
Hum Pathol; 1990 Feb; 21(2):212-7. PubMed ID: 1689691
[TBL] [Abstract][Full Text] [Related]
4. Thrombomodulin as a marker of vascular and lymphatic tumours.
Appleton MA; Attanoos RL; Jasani B
Histopathology; 1996 Aug; 29(2):153-7. PubMed ID: 8872149
[TBL] [Abstract][Full Text] [Related]
5. Mast cell "densities" in vascular proliferations: a preliminary study of pyogenic granuloma, portwine stain, cavernous hemangioma, cherry angioma, Kaposi's sarcoma, and malignant hemangioendothelioma.
Hagiwara K; Khaskhely NM; Uezato H; Nonaka S
J Dermatol; 1999 Sep; 26(9):577-86. PubMed ID: 10535252
[TBL] [Abstract][Full Text] [Related]
6. CD31 immunoreactivity in mesenchymal neoplasms of the skin and subcutis: report of 145 cases and review of putative immunohistologic markers of endothelial differentiation.
DeYoung BR; Swanson PE; Argenyi ZB; Ritter JH; Fitzgibbon JF; Stahl DJ; Hoover W; Wick MR
J Cutan Pathol; 1995 Jun; 22(3):215-22. PubMed ID: 7593814
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical identification of factor VIII-related antigen in endothelial cells of cutaneous lesions of alleged vascular nature.
Burgdorf WH; Mukai K; Rosai J
Am J Clin Pathol; 1981 Feb; 75(2):167-71. PubMed ID: 6781328
[TBL] [Abstract][Full Text] [Related]
8. Immunostaining for CD31 and CD34 in Kaposi sarcoma.
Russell Jones R; Orchard G; Zelger B; Wilson Jones E
J Clin Pathol; 1995 Nov; 48(11):1011-6. PubMed ID: 8543622
[TBL] [Abstract][Full Text] [Related]
9. B72.3 and CD34 immunoreactivity in malignant epithelioid soft tissue tumors. Adjuncts in the recognition of endothelial neoplasms.
Sirgi KE; Wick MR; Swanson PE
Am J Surg Pathol; 1993 Feb; 17(2):179-85. PubMed ID: 7678485
[TBL] [Abstract][Full Text] [Related]
10. Staining for factor VIII related antigen and Ulex europaeus agglutinin I (UEA-I) in 230 tumours. An assessment of their specificity for angiosarcoma and Kaposi's sarcoma.
Leader M; Collins M; Patel J; Henry K
Histopathology; 1986 Nov; 10(11):1153-62. PubMed ID: 3100411
[TBL] [Abstract][Full Text] [Related]
11. Ulex europaeus I lectin as a marker for tumors derived from endothelial cells.
Miettinen M; Holthofer H; Lehto VP; Miettinen A; Virtanen I
Am J Clin Pathol; 1983 Jan; 79(1):32-6. PubMed ID: 6401381
[TBL] [Abstract][Full Text] [Related]
12. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia.
Traweek ST; Kandalaft PL; Mehta P; Battifora H
Am J Clin Pathol; 1991 Jul; 96(1):25-31. PubMed ID: 1712541
[TBL] [Abstract][Full Text] [Related]
13. Different immunoreactivity of endothelial markers in well and poorly differentiated areas of angiosarcomas.
Poblet E; Gonzalez-Palacios F; Jimenez FJ
Virchows Arch; 1996 Jul; 428(4-5):217-21. PubMed ID: 8764929
[TBL] [Abstract][Full Text] [Related]
14. QBEnd/10: a new immunostain for the routine diagnosis of Kaposi's sarcoma.
Sankey EA; More L; Dhillon AP
J Pathol; 1990 Jul; 161(3):267-71. PubMed ID: 2391587
[TBL] [Abstract][Full Text] [Related]
15. Primary vascular tumors of lymph nodes other than Kaposi's sarcoma. Analysis of 39 cases and delineation of two new entities.
Chan JK; Frizzera G; Fletcher CD; Rosai J
Am J Surg Pathol; 1992 Apr; 16(4):335-50. PubMed ID: 1373579
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous vascular proliferations. Part III. Malignant neoplasms, other cutaneous neoplasms with significant vascular component, and disorders erroneously considered as vascular neoplasms.
Requena L; Sangueza OP
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):143-75; quiz 176-8. PubMed ID: 9486670
[TBL] [Abstract][Full Text] [Related]
17. Eruptive epithelioid hemangioendothelioma with spindle cells.
Kanik AB; Hall JD; Bhawan J
Am J Dermatopathol; 1995 Dec; 17(6):612-7. PubMed ID: 8599479
[TBL] [Abstract][Full Text] [Related]
18. Multiple Eruptive Epithelioid Hemangiomas: A Subset of Cutaneous Cellular Epithelioid Hemangioma With Expression of FOS-B.
Llamas-Velasco M; Kempf W; Cota C; Fernández-Figueras MT; Lee J; Ferrara G; Sander C; Shapiro PE; Requena L; Kutzner H
Am J Surg Pathol; 2019 Jan; 43(1):26-34. PubMed ID: 29266025
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma.
Arai E; Kuramochi A; Tsuchida T; Tsuneyoshi M; Kage M; Fukunaga M; Ito T; Tada T; Izumi M; Shimizu K; Hirose T; Shimizu M
J Cutan Pathol; 2006 Jul; 33(7):492-7. PubMed ID: 16872472
[TBL] [Abstract][Full Text] [Related]
20. Endothelial markers in malignant vascular tumours of the liver: superiority of QB-END/10 over von Willebrand factor and Ulex europaeus agglutinin 1.
Anthony PP; Ramani P
J Clin Pathol; 1991 Jan; 44(1):29-32. PubMed ID: 1705261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
